Latest Breaking News On - Takeda pharmaceutical co entyvio - Page 1 : comparemela.com

Autoimmune-disease drugs may reduce vaccine response; antibody treatments ineffective vs Brazil variant By Nancy Lapid FILE PHOTO: FILE PHOTO: The word COVID-19 is reflected in a drop on a syringe needle in this illustration (Reuters) -The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Autoimmune disease treatments may reduce vaccine responses Immunosuppressive drugs for inflammatory diseases like rheumatoid arthritis, multiple sclerosis, and ulcerative colitis can impair the body’s response to the COVID-19 vaccines from Pfizer/BioNTech and Moderna, according to new data. In 133 fully vaccinated people with such conditions, antibody levels and virus neutralization were about three-fold lower than in a comparison group of vaccinated individuals not taking those medicine, researchers reported on Friday on medRxiv ahead of peer review. Mos

South africaUnited statesSouth africanAmgen enbrelRoche rituxanJohnson stelaraEli lillyMaayan lubellAbbvie humiraNancy lapidAlfred kimRegneron pharmaceuticalsWashington university school of medicineColumbia universityTakeda pharmaceutical co entyvioTel aviv university adi stern